Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marion Bertrand

Showing results (31-40 of 47) with videos related to

Pageof 5
Sort By:
Statistics in Medicine|January 29, 2022
A modified self-controlled case series method for event-dependent exposures and high event-related mortality, with application to COVID-19 vaccine safetyYonas Ghebremichael-Weldeselassie, Marie Joëlle Jabagi, Jérémie Botton, et al.
Annals of Internal Medicine|August 22, 2022
Risk for Myocardial Infarction, Stroke, and Pulmonary Embolism Following COVID-19 Vaccines in Adults Younger Than 75 Years in FranceJérémie Botton, Marie Joelle Jabagi, Marion Bertrand, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 26, 2015
Benzodiazepine, psychotropic medication, and dementia: A population-based cohort studyDalia Shash, Tobias Kurth, Marion Bertrand, et al.
BMJ Medicine|March 20, 2023
Effectiveness of BNT162b2, mRNA-1273, and ChAdOx1-S vaccines against severe covid-19 outcomes in a nationwide mass vaccination setting: cohort studyKim Bouillon, Bérangère Baricault, Jérémie Botton, et al.
JAMA Network Open|December 4, 2025
COVID-19 mRNA Vaccination and 4-Year All-Cause Mortality Among Adults Aged 18 to 59 Years in FranceLaura Semenzato, Stéphane Le Vu, Jérémie Botton, et al.
The Lancet Regional Health. Europe|July 5, 2022
Characteristics associated with the residual risk of severe COVID-19 after a complete vaccination schedule: A cohort study of 28 million people in FranceLaura Semenzato, Jérémie Botton, Jérôme Drouin, et al.
Vaccine|September 3, 2024
Risk of heavy menstrual bleeding following COVID-19 vaccination: A nationwide case-control studyJérémie Botton, Marion Bertrand, Marie-Joëlle Jabagi, et al.
Vaccine|April 5, 2025
COVID-19 vaccination rates among pregnant women in France: A nationwide cohort studyClément Bernard, Jérôme Drouin, Stéphane Le Vu, et al.
JAMA|August 26, 2024
Long-Term Prognosis of Patients With Myocarditis Attributed to COVID-19 mRNA Vaccination, SARS-CoV-2 Infection, or Conventional EtiologiesLaura Semenzato, Stéphane Le Vu, Jérémie Botton, et al.
BMC Medical Genetics|March 21, 2013
A genome-wide search for common SNP x SNP interactions on the risk of venous thrombosisNicolas Greliche, Marine Germain, Jean-Charles Lambert, et al.
Pageof 5

Showing results (31-40 of 47) with videos related to

Sort By:
Pageof 5
Statistics in Medicine|January 29, 2022
A modified self-controlled case series method for event-dependent exposures and high event-related mortality, with application to COVID-19 vaccine safetyYonas Ghebremichael-Weldeselassie, Marie Joëlle Jabagi, Jérémie Botton, et al.
Annals of Internal Medicine|August 22, 2022
Risk for Myocardial Infarction, Stroke, and Pulmonary Embolism Following COVID-19 Vaccines in Adults Younger Than 75 Years in FranceJérémie Botton, Marie Joelle Jabagi, Marion Bertrand, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 26, 2015
Benzodiazepine, psychotropic medication, and dementia: A population-based cohort studyDalia Shash, Tobias Kurth, Marion Bertrand, et al.
BMJ Medicine|March 20, 2023
Effectiveness of BNT162b2, mRNA-1273, and ChAdOx1-S vaccines against severe covid-19 outcomes in a nationwide mass vaccination setting: cohort studyKim Bouillon, Bérangère Baricault, Jérémie Botton, et al.
JAMA Network Open|December 4, 2025
COVID-19 mRNA Vaccination and 4-Year All-Cause Mortality Among Adults Aged 18 to 59 Years in FranceLaura Semenzato, Stéphane Le Vu, Jérémie Botton, et al.
The Lancet Regional Health. Europe|July 5, 2022
Characteristics associated with the residual risk of severe COVID-19 after a complete vaccination schedule: A cohort study of 28 million people in FranceLaura Semenzato, Jérémie Botton, Jérôme Drouin, et al.
Vaccine|September 3, 2024
Risk of heavy menstrual bleeding following COVID-19 vaccination: A nationwide case-control studyJérémie Botton, Marion Bertrand, Marie-Joëlle Jabagi, et al.
Vaccine|April 5, 2025
COVID-19 vaccination rates among pregnant women in France: A nationwide cohort studyClément Bernard, Jérôme Drouin, Stéphane Le Vu, et al.
JAMA|August 26, 2024
Long-Term Prognosis of Patients With Myocarditis Attributed to COVID-19 mRNA Vaccination, SARS-CoV-2 Infection, or Conventional EtiologiesLaura Semenzato, Stéphane Le Vu, Jérémie Botton, et al.
BMC Medical Genetics|March 21, 2013
A genome-wide search for common SNP x SNP interactions on the risk of venous thrombosisNicolas Greliche, Marine Germain, Jean-Charles Lambert, et al.
Pageof 5